Equities Analysts Offer Predictions for Curaleaf Q2 Earnings

Curaleaf Holdings, Inc. (OTCMKTS:CURLF) – Research analysts at Seaport Res Ptn decreased their Q2 2025 earnings estimates for Curaleaf in a research report issued on Monday, May 12th. Seaport Res Ptn analyst S. Randhawa now forecasts that the company will post earnings of ($0.07) per share for the quarter, down from their prior forecast of ($0.06). The consensus estimate for Curaleaf’s current full-year earnings is ($0.25) per share. Seaport Res Ptn also issued estimates for Curaleaf’s Q3 2025 earnings at ($0.07) EPS, Q4 2025 earnings at ($0.07) EPS, FY2025 earnings at ($0.29) EPS, Q1 2026 earnings at ($0.07) EPS, Q2 2026 earnings at ($0.06) EPS, Q3 2026 earnings at ($0.06) EPS, Q4 2026 earnings at ($0.05) EPS and FY2026 earnings at ($0.24) EPS.

Curaleaf Stock Performance

CURLF opened at $0.88 on Thursday. The firm has a 50 day moving average of $0.89 and a two-hundred day moving average of $1.40. The firm has a market capitalization of $585.66 million, a PE ratio of -3.05 and a beta of 0.83. The company has a current ratio of 1.11, a quick ratio of 0.51 and a debt-to-equity ratio of 0.85. Curaleaf has a 12-month low of $0.68 and a 12-month high of $6.01.

Curaleaf (OTCMKTS:CURLF) last posted its quarterly earnings results on Thursday, May 8th. The company reported ($0.07) earnings per share for the quarter, meeting the consensus estimate of ($0.07). Curaleaf had a negative return on equity of 13.67% and a negative net margin of 14.82%.

Curaleaf Company Profile

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.